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Abstract
Background: A possible association between human cytomegalovirus (HCMV) infection and
colorectal cancer progression has been inferred by the identification in tumour tissues of HCMV
antigens and specific viral DNA or RNA sequences. To further investigate the relationship between
HCMV and colorectal cancers we developed qualitative and quantitative PCR assay to detect
HCMV DNA in 56 formalin-fixed paraffin-embedded (FFPE) tissue samples from patients belonging
to 4 different histological phenotypes: adenoma; poorly, moderately and well differentiated
adenocarcinomas.
Results: Of the 56 FFPE tested tissue samples, 6 (11%) were positive for HCMV nested PCR
amplification, and more precisely 1 (5%) of 20 cases of adenoma and 5 (21%) of 24 cases of
moderately differentiated adenocarcinoma. No PCR positivity was obtained in samples from well
and poorly differentiated adenocarcinomas.
Conclusion: Our observations suggest that there is no evidence of a direct association between
HCMV and colorectal cancer. Moreover, the results obtained are not supportive of a causal role
of HCMV in the processes of carcinogenesis and/or progression of colorectal cancer. However,
the fact that the virus may present a "hit and run" like-mechanism and HCMV can thus only be
detectable at a particular stage of a processing adenocarcinoma, suggests that a significant number
of colorectal cancers might have been the subject of HCMV infection that could contribute to
trigger the oncogenic differentiation. Our analysis does not exclude the possibility of HCMV
infection subsequent viral clearance.
Background
HCMV is a member of the herpesvirus family and consti-
tutes a major public health problem. HCMV infection is
lifelong, and it manifests differently depending on the
patient's underlying condition and immunological status.
Healthy young people with primary HCMV infection are
often asymptomatic but the latent virus can reactivate to
cause severe diseases in immunocompromised individu-
als [1].
Evidence has already been obtained that HCMV gene
products are capable of transforming cells in vitro and of
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regulating the expression of important host genes, thus
inducing a deregulation of cellular pathways relevant to
colon adenocarcinoma pathogenesis [1-6].
Furthermore, the identification of HCMV nucleic acids
and antigens in tumour tissues, combined with serologi-
cal evidence, has led to a suggestion of a possible associa-
tion between HCMV infection and the progression of
certain malignancies. Indeed, HCMV infection has been
associated with colon adenocarcinoma by several authors
[7-11]. However, other studies have found no evidence of
a direct association between HCMV infection and adeno-
carcinoma malignancy [12-17].
The possible contribution of HCMV in the development
and progression of colorectal cancer is thus still controver-
sial. To further investigate whether HCMV infection could
be responsible for the induction of colorectal cancers and
to obtain a precise assessment of the presence of viral
DNA in tissue samples, we have performed qualitative
and quantitative PCR analyses for HCMV. We have ana-
lysed samples obtained from 58 different patients, includ-
ing 20 adenomas and 38 adenocarcinomas. In order to
study the possible relationship between HCMV infection
and cancer differentiation we have compared adenomas
with adenocarcinomas belonging to 3 different histologi-
cal phenotypes (poorly, moderately and well differenti-
ated).
Results
Genomic DNA quality control
DNA was purified from the histological tissues, and its
quality was tested using PCR primers targeting for the
human albumin gene. Fifty six DNA samples (96.5%) of
the 58 extracted with xylol/ethanol were positive by albu-
min PCR, and were thus considered suitable for subse-
quent analysis for the presence of HCMV DNA. A
representative PCR analysis of albumin gene amplification
in FFPE tissue samples is shown in Figure 1. The presence
of  albumin  DNA was visualized as a band of 120 bp
obtained by using primers specific for albumin gene (see
Methods). These data indicate that in all examined sam-
ples a suitable amplification of albumin  gene was
obtained.
Nested PCR analysis of HCMV in adenomas and 
adenocarcinomas
The nested PCR reaction that amplifies a fragment of 180
bp of the HCMV UL55 gene (see Methods) was carried out
on 56 human DNA samples extracted from adenomas and
adenocarcinomas. The results obtained by nested PCR
with primers I-1/I-2 are presented in Table 1. The UL55
gene was amplified in 1 (5%) of the 20 DNA samples
from patients with adenoma, and in 5 (20.8%) of the 24
samples from patients with moderately differentiated ade-
nocarcinoma. No amplification was obtained in any of
the 5 cases of well-differentiated adenocarcinoma nor in
the 7 cases of poorly differentiated adenocarcinoma.
Since the presence of HCMV DNA was found only in a
reduced subset of colorectal cancers, these results suggest
that there is no evidence of a direct causal association
between HCMV infection and induction of poorly or well-
differentiated adenocarcinomas. However, viral DNA was
found in approximately 21% of moderately differentiated
adenocarcinomas, suggesting that the virus, although not
essential to progression towards the transforming pheno-
type, could conceivably have a role in the initiation of the
tumorigenic event.
In Figure 2 the results obtained for 5 of the 56 clinical
samples tested in the second round of PCR are reported;
samples 4 and 5 were considered positive since a 182 bp
band corresponding to the expected size of viral amplicon
was found.
PCR analysis of albumin gene Figure 1
PCR analysis of albumin gene. DNA extracted from FFPE samples was amplified for albumin gene using primers described in 
Methods. Amplification yielded a band of 120 bp. As positive control (+), human DNA from non-FFPE tissue was used; as neg-
ative control (N), PCR master mix without DNA was used. Clinical samples, lanes 1–10. DNA molecular weight marker, M.
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Quantitative PCR analysis
We developed a real-time PCR quantitative analysis using
SYBR® Green I to quantify the viral load in the nested PCR-
HCMV positive samples. A standard curve was generated
by 10 fold serial dilutions (8 × 105 – 8 copies) of a plasmid
containing a single copy of HCMV US28 gene. The regres-
sion curve analysis consisting of 5 points tested in tripli-
cate gave a reaction with an efficiency of 100% and a
Spearmann's correlation coefficient (R2) of 0.99. Quanti-
tative PCR analysis of DNA extracts from FFPE tissues did
not allow to obtain reproducible data since the efficiency
of PCR was lower (60%, R2 = 0.82) than the 100% stand-
ard required. Also the replicate values, from a paraffin-
embedded tissue, were discordant (Ct standard deviation
≥ 1) and the dissociation curve highlighted the presence of
non specific amplified products in target samples.
The difficulty in obtaining reliable data from clinical sam-
ples is probably linked to the process of paraffin removal
that may result in formation of inhibitory substances
[18,19] which interfere with the PCR reaction and reduce
PCR efficiency [20].
Although this method did not allow quantitation in
deparaffinised samples, the real time PCR assay con-
firmed the qualitative positivity obtained by nested PCR
in 2 tested samples (data not shown).
Discussion
The role of HCMV in the development and progression of
colorectal cancers has not yet been clarified. The presence
of HCMV antigens and nucleic acids in colorectal cancers
has been obtained by means of molecular and virologic
studies and a direct relationship between the virus and
cancer was suggested [7-11]. However, in other studies, no
evidence of a direct association between colorectal cancer
and HCMV infection was found [12-17].
More specifically, Harkins et al. [11] have conducted a
study on 29 specimens of colorectal polyps and adenocar-
Table 1: Phenotype and PCR results for FFPE samples of colorectal cancer
clinic phenotype number of samples HCMV PCR positive samples
poorly differentiated adenocarcinomas 70
moderately differentiated adenocarcinomas 24 5
well differentiated adenocarcinomas 50
adenomas 20 1
total 56 6
Nested PCR analysis of viral DNA from representative colorectal cancer samples Figure 2
Nested PCR analysis of viral DNA from representative colorectal cancer samples. DNA extracted from deparaffin-
ised tissues was amplified with I-1/I-2 primers. Amplification of inner fragment yielded a band of 182 bp. Positive control (+); 
negative control (N); clinical samples, lanes 1–5; DNA molecular weight marker, M.
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cinomas from different patients using immunohisto-
chemistry with two different antibodies, and reported the
presence of HCMV proteins in about 80% of polyps and
85% of adenocarcinomas, but not in adjacent healthy tis-
sues. In addition, by means of PCR and DNA sequencing,
the presence of viral nucleic acids was detected in 6
tumours (5 adenocarcinomas and 1 polyp) that were
immunoreactive for HCMV, whereas it was not detected
in healthy tissues from 3 of the same 6 patients. These
results suggested a possible causative association between
HCMV and colorectal cancer. Akintola-Ogunremi et al.
[17] examined 23 colorectal hyperplastic polyps, 65 color-
ectal adenomas and 51 colorectal adenocarcinomas by
immunohistochemical analysis with two different anti-
bodies. No nuclear HCMV antigen positivity was detecta-
ble in any of the studied cases. In addition, PCR analysis
failed to detect viral DNA in 24 selected cases showing
non-specific cytoplasmic immunostaining. These results
are in stark contrast to those reported by Harkins et al
[11], since no evidence of HCMV DNA and proteins in
human colorectal adenocarcinomas and their precursor
lesions was found.
Knösel et al [16] investigated the presence of HCMV DNA
and antigens, by using PCR analysis and immunohisto-
chemistry. Fifty seven primary tumours and 20 metastases
of fresh colorectal cancer tissue were tested, including 13
tumour pairs (primary and metastases) from the same
patient. Four (7%) of 57 primary tumours were found
positive for HCMV DNA by PCR, whereas all metastases
were negative. In addition, no specific staining was
detected by immunohistochemistry analysis. Although
these results confirmed the results of Akintola-Ogunremi
et al [17] indicating that there is no direct association
between HCMV infection and progression or formation of
metastases in colorectal cancer, evidence of HCMV posi-
tivity in a small number of colorectal neoplasms was
found in the primary tumours.
Given the controversial conclusions of the reported
results, we further investigated the issue by establishing a
specific qualitative PCR analysis and a quantitative PCR
reaction for HCMV viral load determination.
The nested PCR analysis conducted in our laboratory
allowed the identification of HCMV sequence in 6
(10.7%) of 56 tissue samples tested, and more precisely in
1 (5%) of 20 cases of adenoma and 5 (20.8%) of 24 cases
of moderately differentiated adenocarcinomas. However,
there was no evidence of HCMV DNA in any of 5 cases of
well-differentiated adenocarcinoma nor in 7 cases of
poorly differentiated adenocarcinoma, suggesting the lack
of a causative association between virus infection and can-
cer development in these two groups of adenocarcinomas.
Of interest is the detection of HCMV DNA in 20.8% of
moderately differentiated adenocarcinomas, whereas it
was undetectable in poorly and well-differentiated carci-
nomas, similar to the findings of Knösel et al. [16]. It has
been reported, in transformed HCMV cells, that the
HCMV infection could present a "hit and run" oncogenic-
like mechanism [2,21], though viral DNA is undetectable
in metastases. It's presence in earlier histological stages
may suggest that the presence of HCMV DNA might not
be essential to progress toward the transforming pheno-
type. Following the "hit and run" like mechanism, the
virus could mediate cellular transformation through an
initial hit, while maintenance of the transformed state is
compatible with the loss of viral molecules. Thus, the fact
that we have detected viral DNA only in moderately differ-
entiated carcinomas may reflect the inability of HCMV to
infect poorly differentiated cancer cells [22].
The quantitative real time PCR analysis was validated on
HCMV DNA strains, but could not give reproducible data
on DNA extracted from paraffin embedded samples. This
could potentially be due to the presence of inhibitors in
biopsy samples that can interfere with the PCR. Quantifi-
cation of HCMV viral load by real-time PCR can yield
important information on the timing of HCMV infection.
Therefore, validation of the real-time PCR protocol in
non-paraffin embedded samples could represent a useful
tool for the identification of HCMV in human cancer.
Conclusion
In conclusion, our observations, together with those of
other authors [16,17] suggest that there is no evidence of
a direct association between HCMV and colorectal cancer.
Moreover, there is no evidence supporting that HCMV can
fulfil the necessary criteria for defining a causative role in
the process of carcinogenesis and or progression of color-
ectal cancer. One of these requirements is, in fact, the reg-
ular presence and persistence of the nucleic acid of the
respective infectious agent in cells of the specific tumour
type [23,24].
However, the fact that the virus may present a "hit and
run" like-mechanism and that it was found only in a par-
ticular stage of a processing adenocarcinomas, provides a
useful indication that a certain type of adenocarcinoma
have been infected by HCMV and that this could have
contributed to trigger the oncogenic differentiation.
Methods
Specimen collection
The specimens included in this study consisted of 10%
FFPE tissue blocks of colorectal tumours from the archives
of the Pathology section of the Department of Pathology,
University of Verona, Italy. Samples of 58 biopsies were
obtained from different patients of which 20 were adeno-Infectious Agents and Cancer 2009, 4:6 http://www.infectagentscancer.com/content/4/1/6
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mas and 38 adenocarcinomas. Of the 38 adenocarcino-
mas, 5 were well differentiated, 25 moderately
differentiated and 8 poorly differentiated.
Biopsies and histology
Samples were independently reviewed by two patholo-
gists (AZ and FM) and classified according to the WHO
classification of tumours of the digestive system. In case of
discrepancy, a consensus was reached by reviewing dis-
cordant cases at a multi-head microscope. Representative
tissue blocks were selected for DNA extraction, selecting
blocks with high tumour content.
Isolation of genomic DNA from paraffin-embedded tissues
Four 3 μm sections of each sample were deparaffinised
with xylol/ethanol, collected into a 1.5 ml Eppendorf tube
containing 100 μl of lysis solution: 0.1 M NaCl, 0.15 M
EDTA pH 8.0, 0.1 M Tris-HCl pH 8.0, 1% SDS, 45.8 mM
β-mercaptoethanol and 100 μg Proteinase K. The tubes
were incubated at 55°C for 3 hours, followed by Protein-
ase K heat inactivation. Samples were centrifuged at room
temperature at 10.000 g for 5 min. The supernatants were
collected and stored at -20°C, prior to the PCR amplifica-
tion procedure.
Polymerase chain reaction analysis
Since DNA extracted from paraffin-embedded tissue
might be partially degraded during formalin fixation or
paraffin embedding [25], DNA quality was tested using
the following PCR primers specific for the human albumin
gene: primer alb fw (5'gctgtcatctcttgtgggctgt 3') and primer
alb rv (5'actcatgggagctgctggttc 3'). A total of 56 samples
were considered suitable to be tested for the presence of
HCMV viral DNA.
The analysis of HCMV in DNA samples was performed by
developing a nested PCR reaction with external and inter-
nal primers specific for HCMV UL55  gene region that
encodes for the envelope glycoprotein B. Oligonucleotide
primers used to detect HCMV DNA have been described
previously [26] and are summarised in Table 2. External
primers (E-1/E-2) amplify a 267 bp fragment, while inter-
nal primers (I-1/I-2) amplify a 182 bp fragment. All sam-
ples were tested in duplicate and samples positive for
HCM UL55 gene were tested at least in triplicate.
The first-round of PCR amplification was performed in a
20 μl reaction containing 2–5 μl of each genomic DNA
sample. As positive controls for PCR reactions 3 different
HCMV DNA samples were used: DNA extracted from
human fibroblasts cultured in vitro and infected with an
HCMV strain from a newborn baby with congenital infec-
tion and viral DNA of the two laboratory strains AD169
and Towne. Each experiment was conducted using posi-
tive and negative controls.
For the first amplification round, after an initial denatur-
ing step at 94°C for 5 min, 35 cycles of denaturation at
94°C for 30 sec, annealing at 58°C for 30 sec, extension
at 72°C for 30 sec, were made, followed by a final exten-
sion at 72°C for 6 min. The amplified products were sub-
jected to the second round of PCR using the primer pair I-
1/I-2 and 1 μl of the first round amplification product.
Cycling program was performed as follows: 94°C for 5
min, 1 cycle; 94°C for 30 sec, 59°C for 30 sec, 72°C for
30 sec, 40 cycles; 72°C for 5 min, 1 cycle.
At the end of the amplification 15–20 μl of each product
were analysed on 2.5% w/v agarose gels by electrophore-
sis.
Real-time PCR
The real-time quantitative PCR assay was performed on an
ABI Prism 7000 real time PCR instrument (Applied Bio-
systems). Primers used for amplification of HCMV US28
gene in real-time reaction are summarised in Table 3 and
were designed using Primer Express V2.0 software
(Applied Biosystems) on the basis of the sequence of
US28 gene of AD169 laboratory strain (GenBank acces-
sion number: NC_001347) and then controlled by align-
ing sequences with BLAST. The reaction mixture was set
using the Real Master Mix 2.5X (Eppendorf AG) contain-
ing SYBR® Green I. Primers were used at a final concentra-
tion of 300 nM. Each sample was tested in triplicate.
Reactions were performed under the following condi-
tions: 95°C for 5 min, followed by 45 cycles at 95°C for
20 sec and 60°C for 1 min.
Data were collected and analysed by Sequence Detection
System Software (Applied Biosystems).
Table 2: Primers used for HCMV DNA amplification by nested PCR
primer sequence amplicon length UL55 gene position
E-1 TCCAACACCCACAGTACCCGT 267 bp 655 to 675
E-2 CGGAAACGATGGTGTAGTTCG 902 to 922
I-1 GTCAAGGATCAGTGGCACAGC 182 bp 685 to 705
I-2 GTAGCTGGCATTGCGATTGGT 847 to 867
Primers used for amplification of the HCMV glycoprotein B (UL55) gene in nested PCR. External primers amplify a 267 bp fragment, while internal 
primers amplify a 182 bp fragmentInfectious Agents and Cancer 2009, 4:6 http://www.infectagentscancer.com/content/4/1/6
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